Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Catherine Gutierrez

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Clinical Lymphoma, Myeloma & Leukemia|May 1, 2023
Autologous Stem Cell Transplant in Lymphoma Using a Noncryopreserved Platform: An Adapted Sequential Conditioning Maintaining Dose Intensity Does not Affect Transplantation OutcomesMauricio Sarmiento, Patricio Rojas, Catherine Gutierrez, et al.
Hematology (Amsterdam, Netherlands)|November 29, 2024
Comparison between different reduced intensity conditioning regimens in AML/MDS patients in a Latin American center of adult stem cell transplantationJosé Salinas, Yorman Flores, Patricio Rojas, et al.
Neuro-Oncology|December 19, 2022
Corrigendum to: Molecular biomarker-defined brain tumors: Epidemiology, validity, and completeness in the United StatesJ Bryan Iorgulescu, Chuxuan Sun, Corey Neff, et al.
Neuro-Oncology|April 23, 2022
Molecular biomarker-defined brain tumors: Epidemiology, validity, and completeness in the United StatesJ Bryan Iorgulescu, Chuxuan Sun, Corey Neff, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 26, 2025
Gene Copy Deletion of STK11, KEAP1, and SMARCA4: Clinicopathologic Features and Association With the Outcomes of Immunotherapy With or Without Chemotherapy in Nonsquamous NSCLCMalini M Gandhi, Arielle Elkrief, Catherine Gutierrez Moore, et al.
The Journal of Clinical Investigation|July 18, 2023
SF3B1 mutation and ATM deletion codrive leukemogenesis via centromeric R-loop dysregulationMartina Cusan, Haifeng Shen, Bo Zhang, et al.
Nature Cancer|December 23, 2021
Multifunctional barcoding with ClonMapper enables high-resolution study of clonal dynamics during tumor evolution and treatmentCatherine Gutierrez, Aziz M Al'Khafaji, Eric Brenner, et al.
Blood Advances|June 30, 2026
A Phase Ib/II study of ceralasertib, a selective inhibitor of ATR, in patients with relapsed or refractory MDS and CMMLAndrew M Brunner, Yiwen Liu, Jacqueline S Garcia, et al.
Cancer Cell|March 10, 2021
A hotspot mutation in transcription factor IKZF3 drives B cell neoplasia via transcriptional dysregulationGregory Lazarian, Shanye Yin, Elisa Ten Hacken, et al.
Cancer Research|October 23, 2021
Activation of <i>Notch</i> and <i>Myc</i> Signaling via B-cell-Restricted Depletion of <i>Dnmt3a</i> Generates a Consistent Murine Model of Chronic Lymphocytic LeukemiaAnat Biran, Shanye Yin, Helene Kretzmer, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Clinical Lymphoma, Myeloma & Leukemia|May 1, 2023
Autologous Stem Cell Transplant in Lymphoma Using a Noncryopreserved Platform: An Adapted Sequential Conditioning Maintaining Dose Intensity Does not Affect Transplantation OutcomesMauricio Sarmiento, Patricio Rojas, Catherine Gutierrez, et al.
Hematology (Amsterdam, Netherlands)|November 29, 2024
Comparison between different reduced intensity conditioning regimens in AML/MDS patients in a Latin American center of adult stem cell transplantationJosé Salinas, Yorman Flores, Patricio Rojas, et al.
Neuro-Oncology|December 19, 2022
Corrigendum to: Molecular biomarker-defined brain tumors: Epidemiology, validity, and completeness in the United StatesJ Bryan Iorgulescu, Chuxuan Sun, Corey Neff, et al.
Neuro-Oncology|April 23, 2022
Molecular biomarker-defined brain tumors: Epidemiology, validity, and completeness in the United StatesJ Bryan Iorgulescu, Chuxuan Sun, Corey Neff, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 26, 2025
Gene Copy Deletion of STK11, KEAP1, and SMARCA4: Clinicopathologic Features and Association With the Outcomes of Immunotherapy With or Without Chemotherapy in Nonsquamous NSCLCMalini M Gandhi, Arielle Elkrief, Catherine Gutierrez Moore, et al.
The Journal of Clinical Investigation|July 18, 2023
SF3B1 mutation and ATM deletion codrive leukemogenesis via centromeric R-loop dysregulationMartina Cusan, Haifeng Shen, Bo Zhang, et al.
Nature Cancer|December 23, 2021
Multifunctional barcoding with ClonMapper enables high-resolution study of clonal dynamics during tumor evolution and treatmentCatherine Gutierrez, Aziz M Al'Khafaji, Eric Brenner, et al.
Blood Advances|June 30, 2026
A Phase Ib/II study of ceralasertib, a selective inhibitor of ATR, in patients with relapsed or refractory MDS and CMMLAndrew M Brunner, Yiwen Liu, Jacqueline S Garcia, et al.
Cancer Cell|March 10, 2021
A hotspot mutation in transcription factor IKZF3 drives B cell neoplasia via transcriptional dysregulationGregory Lazarian, Shanye Yin, Elisa Ten Hacken, et al.
Cancer Research|October 23, 2021
Activation of <i>Notch</i> and <i>Myc</i> Signaling via B-cell-Restricted Depletion of <i>Dnmt3a</i> Generates a Consistent Murine Model of Chronic Lymphocytic LeukemiaAnat Biran, Shanye Yin, Helene Kretzmer, et al.
Pageof 3